Page last updated: 2024-08-22

4-chloro-7-nitrobenzofurazan and palmitic acid

4-chloro-7-nitrobenzofurazan has been researched along with palmitic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pagano, RE; Salman, M1
An, SY; Choi, SE; Ha, ES; Han, SJ; Kang, Y; Kim, DJ; Kim, HJ; Kim, TH; Lee, KW; Lee, MS1

Other Studies

2 other study(ies) available for 4-chloro-7-nitrobenzofurazan and palmitic acid

ArticleYear
Use of a fluorescent analog of CDP-DAG in human skin fibroblasts: characterization of metabolism, distribution, and application to studies of phosphatidylinositol turnover.
    Journal of lipid research, 1997, Volume: 38, Issue:3

    Topics: 4-Chloro-7-nitrobenzofurazan; Cells, Cultured; Chromatography, Thin Layer; Cyclohexanones; Cytidine Diphosphate Diglycerides; Enzyme Inhibitors; Fibroblasts; Fluorescent Dyes; Humans; Interleukin-1; Lipoprotein Lipase; Membrane Lipids; Microscopy, Fluorescence; Oleic Acid; Palmitic Acid; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositols; Platelet-Derived Growth Factor; Propranolol; Pyrimidinones; Thiazoles

1997
Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB.
    Metabolism: clinical and experimental, 2012, Volume: 61, Issue:8

    Topics: 4-Chloro-7-nitrobenzofurazan; Blotting, Western; Deoxyglucose; Enzyme Activation; Fibroblast Growth Factors; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; I-kappa B Kinase; Insulin; Insulin Resistance; MAP Kinase Kinase 4; Muscle Fibers, Skeletal; NF-kappa B p50 Subunit; Palmitic Acid; Phosphorylation; Polymerase Chain Reaction; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction

2012